Efficacy and Safety of Elbasvir/Grazoprevir in Hepatitis C Virus GT1- and GT4-Infected People Aged 65 Years or Older
暂无分享,去创建一个
O. Shibolet | E. Barr | B. Haber | R. Nahass | C. Peng | M. Robertson | S. Flamm | P. Hwang
暂无分享,去创建一个
O. Shibolet | E. Barr | B. Haber | R. Nahass | C. Peng | M. Robertson | S. Flamm | P. Hwang